FDA Adverse Event Malfunction Summary report: N

COULTER ACT 5DIFF HEMATOLOGY ANALYZER

MDR report key: 2210133 · Received August 5, 2011

Report

Report Number
1061932-2011-01060
Event Type
Malfunction
Date Received
August 5, 2011
Date of Event
February 17, 2010
Report Date
February 17, 2010
Manufacturer
BECKMAN COULTER, INC.
Product Code
GKZ
PMA / PMN Number
K992511
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
ND, US
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

THE CUSTOMER CONTACTED BECKMAN COULTER, INC CALL CENTER TO REQUEST SERVICE FOR THE ERRONEOUS HIGH BASOPHIL% TEST RESULTS. THE CUSTOMER DID NOT PROVIDE PT DATA OR PRINTOUTS. IT IS UNK THE DATES OF TESTING, NUMBER OF PT SAMPLES INVOLVED, OR IF THERE WERE INSTRUMENT GENERATED FLAGS OR ERROR MESSAGES ASSOCIATED WITH THE TEST RESULTS. THE INSTRUMENT WAS PERFORMING WITH QC SPECS WITH RESPECT TO CONTROLS (ACCURACY) AND REPRODUCIBILITY (PRECISION). CONTROLS WERE RUN BEFORE AND AFTER THIS INCIDENT AND RECOVERED WITHIN LIMITS. ON (B)(6) 2010, THE FIELD SERVICE ENGINEER (FSE) REPLACED VALVE 14 AND PERFORMED REPRODUCIBILITY. VERIFIED INSTRUMENT PERFORMANCE TO SPECS. ROOT CAUSE IS UNK BUT MAYBE RELATED TO THE HARDWARE REPLACED BY FSE DURING INSTRUMENT SERVICING. THIS REPORTABLE EVENT WAS IDENTIFIED DURING A RETROSPECTIVE REVIEW CONDUCTED BETWEEN (B)(6) 2008 AND (B)(6) 2010 OF COMPLAINTS FOR ADD'L REPORTABLE EVENTS.

Description of Event or Problem · 1

CUSTOMER REPORTED ERRONEOUS HIGH PASOPHIL% TEST RESULTS WERE OBTAINED WHEN USING THE COULTER ACT 5DIFF HEMATOLOGY ANALYZER. THE TEST RESULTS WERE DETERMINED TO BE ERRONEOUS WHEN COMPARED TO TEST RESULTS OBTAINED FROM A REFERENCE LAB. TEST RESULTS WERE NOT PROVIDED. ERRONEOUS TEST RESULTS WERE REPORTED OUT OF THE LAB. NO REPORTS OF DEATH OR SERIOUS INJURY, AND NO AFFECT TO PT TREATMENT AS A RESULT OF THIS EVENT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 COULTER ACT 5DIFF HEMATOLOGY ANALYZER GKZ BECKMAN COULTER, INC. NA NA

Patients

Seq Age Sex Outcome Treatment
1 UNK